Journal of Surgery Concepts & Practice ›› 2019, Vol. 24 ›› Issue (06): 517-521.doi: 10.16139/j.1007-9610.2019.06.010

• Original article • Previous Articles     Next Articles

Efficacy of transjugular intrahepatic portosystemic shunt in treatment of portal hypertension: A comparison of Viatorr stent and covered stent combined with bare (metal) stent

BAO Yingjun, GU Junpeng, ZHANG Haixiao, ZHU Diwen, REN Weixin   

  1. Department of Interventional Radiology, First Affiliated Hospital of Xinjiang Medical University, Xinjiang Urumqi 830054, China
  • Received:2019-04-01 Online:2019-11-25 Published:2019-12-25

Abstract: Objective To compare shunt patency and hepatic encephalopathy rates following transjugular intrahepatic portosystemic shunt (TIPS) creation between Viatorr and covered stent combined with bare(metal) stent as combined stent. Methods From May 2014 to September 2017, the patients with cirrhosis and portal hypertension in our center had TIPS creation including 46 cases in Viatorr stent group and 79 cases in covered stent combined with bare(metal) stent. Portal venous pressure before and after TIPS creation, shunt patency and hepatic encephalopathy rates were compared between two groups. Results There was no significant difference in portal venous pressure before and after TIPS creation between Viatorr stent group and covered stent combined with bare(metal) stent. After 12 months of follow-up, patency rate was 97.8% in Viatorr stent group and 83.5% in covered stent combined with bare(metal) stent. Hepatic encephalopathy rate was 4.3% in Viatorr stent group and 11.4% in covered stent combined with bare(metal) stent. Conclusions TIPS creation with Viatorr stent improves short-term shunt patency rate. However, there was no statistical difference in hepatic encephalopathy rate between use Viatorr stent and combined stent graft.

Key words: Portal hypertension, Viatorr stent, Covered stent combined with bare (metal) stent, Shunt patency rate, Hepatic encephalopathy

CLC Number: